Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-10-4
|
pubmed:abstractText |
The hemodynamic changes of metoprolol (Met, 50 mg.kg-1.d-1, po, 3 wk) withdrawal for 1 day and the effects of nifedipine (Nif) and m-nifedipine (m-Nif) on these changes were observed in pressure overload hypertrophy in rats by abdominal aortic constriction for 4 wk. Both Nif and m-Nif (10 mg.kg-1.d-1, respectively, po, 3 wk) significantly attenuated the increase of MAP (from 14.3 +/- 2.3 to 12.9 +/- 2.3 and 11.3 +/- 2.4 kPa, respectively, n = 6-7, P < 0.05) and decrease the abnormal development of systolic function of left ventricle after Met withdrawal. Radioreceptor assay indicates that Nif and m-Nif can prevent the up-regulation of myocardium beta-receptors in left ventricular hypertrophy and large dose of Met exposure for a long time. These results suggest that calcium antagonists administered with beta-blockers can prevent beta-receptor blocker withdrawal syndrome.
|
pubmed:language |
chi
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0513-4870
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
21-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7660786-Animals,
pubmed-meshheading:7660786-Hemodynamics,
pubmed-meshheading:7660786-Hypertrophy, Left Ventricular,
pubmed-meshheading:7660786-Isomerism,
pubmed-meshheading:7660786-Male,
pubmed-meshheading:7660786-Metoprolol,
pubmed-meshheading:7660786-Myocardium,
pubmed-meshheading:7660786-Nifedipine,
pubmed-meshheading:7660786-Rats,
pubmed-meshheading:7660786-Rats, Sprague-Dawley,
pubmed-meshheading:7660786-Receptors, Adrenergic, beta,
pubmed-meshheading:7660786-Substance Withdrawal Syndrome
|
pubmed:year |
1995
|
pubmed:articleTitle |
[Effects of calcium antagonists on withdrawal of beta-receptor blockers in rats during left ventricular hypertrophy].
|
pubmed:affiliation |
Department of Cardiovascular Pharmacology, Nanjing Medical University.
|
pubmed:publicationType |
Journal Article,
English Abstract
|